Evidence map›Paper›PMID 35950772›Full record

ArticleMicrobiology spectrum2022

Characterization of Extensively Drug-Resistant (XDR) Carbapenemase-Producing

Jessica J Bartoszko, Robyn Mitchell, Kevin Katz, Michael Mulvey, Laura Mataseje, Canadian Nosocomial Infection Surveillance Program (CNISP) Carbapenemase-Producing Organisms (CPO) Working Group

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Three separate acquisitions of blaEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jessica J BartoszkoCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Robyn MitchellCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Kevin KatzDepartment of Infection Prevention and Control, North York General Hospitalgrid.416529.d, Toronto, Ontario, Canada.
Michael MulveyNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Laura MatasejeNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0002-8014-1107
Canadian Nosocomial Infection Surveillance Program (CNISP) Carbapenemase-Producing Organisms (CPO) Working Group
Public Health Agency of Canada · CANorth York General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data regarding the epidemiology of extensively drug-resistant (XDR) carbapenemase-producing

Indexed as

Enterobacteriaceae InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCanadaDrug Resistance, BacterialEscherichia coliHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseAMRantimicrobial resistanceAROcarbapenease-producing EnterobacteralesCPEdrug-resistant

Identifiers

PMID35950772
PMCPMC9430190
OpenAlexW4290805816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.